Immunotherapy
Immunotherapy is an intervention with 103 clinical trials. Currently 50 active trials ongoing. Historical success rate of 82.4%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
38
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
60.9%
14 of 23 finished
39.1%
9 ended early
50
trials recruiting
103
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors
Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer
Testing Repeat Radiation Therapy for Recurrent Non-small Cell Lung Cancer
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
Clinical Trials (103)
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors
Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer
Testing Repeat Radiation Therapy for Recurrent Non-small Cell Lung Cancer
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases
Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative
Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma
Yang et al. Anti-PD-1/CTLA-4 Dual Immunotherapy for LARC
Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 103